Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2018 1
2020 1
2021 2
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium.
Meurisse M, Catteau L, van Loenhout JAF, Braeye T, De Mot L, Serrien B, Blot K, Cauët E, Van Oyen H, Cuypers L, Belgian Collaborative Group On Covid-Hospital Surveillance, Covid-Genomics Belgium Consortium, Robert A, Van Goethem N. Meurisse M, et al. Among authors: de mot l. Vaccines (Basel). 2023 Feb 7;11(2):378. doi: 10.3390/vaccines11020378. Vaccines (Basel). 2023. PMID: 36851257 Free PMC article.
Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021-2022.
Van Goethem N, Chung PYJ, Meurisse M, Vandromme M, De Mot L, Brondeel R, Stouten V, Klamer S, Cuypers L, Braeye T, Catteau L, Nevejan L, van Loenhout JAF, Blot K. Van Goethem N, et al. Among authors: de mot l. Viruses. 2022 Jun 14;14(6):1297. doi: 10.3390/v14061297. Viruses. 2022. PMID: 35746768 Free PMC article.
Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study.
Robalo Q, De Mot L, Vandromme M, Van Goethem N, Gabrio A, Chung PYJ, Meurisse M, Belgian Collaborative Group On Covid-Hospital Surveillance, Catteau L, Thijs C, Blot K. Robalo Q, et al. Among authors: de mot l. Vaccines (Basel). 2022 Dec 21;11(1):14. doi: 10.3390/vaccines11010014. Vaccines (Basel). 2022. PMID: 36679859 Free PMC article.
Downregulation of Ubiquitin-Specific Protease 15 (USP15) Does Not Provide Therapeutic Benefit in Experimental Mesial Temporal Lobe Epilepsy.
Häussler U, Neres J, Vandenplas C, Eykens C, Kadiu I, Schramm C, Fleurance R, Stanley P, Godard P, de Mot L, van Eyll J, Knobeloch KP, Haas CA, Dedeurwaerdere S. Häussler U, et al. Among authors: de mot l. Mol Neurobiol. 2024 Apr;61(4):2367-2389. doi: 10.1007/s12035-023-03692-2. Epub 2023 Oct 24. Mol Neurobiol. 2024. PMID: 37874479 Free PMC article.
Adjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72/AS01 in Bacillus Calmette-Guérin-Vaccinated Adults.
van den Berg RA, De Mot L, Leroux-Roels G, Bechtold V, Clement F, Coccia M, Jongert E, Evans TG, Gillard P, van der Most RG. van den Berg RA, et al. Among authors: de mot l. Front Immunol. 2018 Mar 26;9:564. doi: 10.3389/fimmu.2018.00564. eCollection 2018. Front Immunol. 2018. PMID: 29632533 Free PMC article. Clinical Trial.